What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Dominique Figarella-Branger mostly deals with Pathology, Internal medicine, Glioma, Surgery and Oncology.
Dominique Figarella-Branger studies Pathology, focusing on Immunohistochemistry in particular.
Dominique Figarella-Branger combines subjects such as Endocrinology and Genotype with his study of Internal medicine.
The Glioma study combines topics in areas such as Isocitrate dehydrogenase and Ependymoma.
His Ependymoma study integrates concerns from other disciplines, such as Medulloblastoma and Cohort.
His research integrates issues of Cancer, Concordance, Oligodendroglioma and Hazard ratio in his study of Oncology.
His most cited work include:
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. (6125 citations)
- New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs (402 citations)
- International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading (389 citations)
What are the main themes of his work throughout his whole career to date?
Dominique Figarella-Branger spends much of his time researching Pathology, Internal medicine, Cancer research, Glioma and Oncology.
His work in Pathology covers topics such as Neural cell adhesion molecule which are related to areas like Cell adhesion molecule.
His studies examine the connections between Internal medicine and genetics, as well as such issues in Endocrinology, with regards to Adenoma.
His studies deal with areas such as Carcinogenesis, Cell culture and Immunology as well as Cancer research.
His Glioma research integrates issues from Isocitrate dehydrogenase and IDH1.
Dominique Figarella-Branger has researched Oncology in several fields, including Cancer and Cohort.
He most often published in these fields:
- Pathology (42.25%)
- Internal medicine (24.63%)
- Cancer research (15.50%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (24.63%)
- Cancer research (15.50%)
- Glioma (14.68%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cancer research, Glioma, Oncology and Pathology.
In his study, which falls under the umbrella issue of Internal medicine, Resection is strongly linked to Gastroenterology.
Dominique Figarella-Branger interconnects Carcinogenesis, Cancer, Somatic cell, Fusion gene and Mutation in the investigation of issues within Cancer research.
His work carried out in the field of Glioma brings together such families of science as Isocitrate dehydrogenase, Karnofsky Performance Status and IDH1.
His Oncology study combines topics in areas such as Medulloblastoma, Regimen, Anaplastic astrocytoma and Glioblastoma.
Dominique Figarella-Branger studies Embryonal tumors, a branch of Pathology.
Between 2018 and 2021, his most popular works were:
- cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. (87 citations)
- CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. (37 citations)
- The molecular landscape of ETMR at diagnosis and relapse (27 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His primary scientific interests are in Cancer research, Glioma, Internal medicine, Oncology and Glioblastoma.
He combines subjects such as Cell culture, Progression-free survival, Cell growth, Neuraminidase and Carcinogenesis with his study of Cancer research.
He works mostly in the field of Progression-free survival, limiting it down to concerns involving Oncogene Fusion and, occasionally, Solitary fibrous tumor and Survival rate.
Dominique Figarella-Branger has researched Glioma in several fields, including Immunohistochemistry, Ki-67, Isocitrate dehydrogenase and Sanger sequencing.
Dominique Figarella-Branger regularly links together related areas like Neurosurgery in his Internal medicine studies.
His Grading study, which is part of a larger body of work in Oncology, is frequently linked to In patient, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
